Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov 15;49(47):8885-8.
doi: 10.1002/anie.201001242.

The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA

Ye Fu  1 , Qing Dai, Wen Zhang, Jin Ren, Tao Pan, Chuan He
Affiliations

The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA

Ye Fu et al. Angew Chem Int Ed Engl. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distinct domains and proposed function of ABH8. a) ABH8 contains three domains: the N-terminal RNA recognition motif (RRM; blue), the middle iron/αKG-dependent AlkB domain (red), and the C-terminal methyltransferase domain (green). The C-terminal domain is homologous to a tRNA modification methyltransferase Trm9 in yeast. b) The anticodon wobble-base U*34 in higher eukaryotes tRNAGly(U*CC) can be hypermodified. c) Examples of hypermodification on U*34: 5-carboxymethyluridine (cm5U), 5-methoxycarbonylmethyluridine (mcm5U), and 5-methoxycarbonylhydroxymethyluridine (mchm5U). d) The proposed sequential modification of the wobble U*34 in a 17-mer RNA that contains the anticodon stem–loop of tRNAGly(U*CC) by the two catalytic domains of ABH8.
Figure 2
Figure 2
Hydroxylation of mcm5U in a 17-mer tRNAGly(U*CC) anticodon stem-loop. a) The chemically synthesized 17-mer RNA oligonucleotide resembling the tRNAGly(U*CC) anticodon stem-loop was treated with mABH81−340 in the presence of iron(II) and α-KG. The HPLC traces show the appearance of a peak for the product (S)-mchm5U when mcm5U is converted in the presence of the enzyme. b) HRMS data of the product (S)-mchm5U confirms the addition of a hydroxy group to mcm5U. MES = 2-(N-morpholino)ethanesulfonic acid.
Scheme 1
Scheme 1
Synthesis of mcm5U phosphoramidite (5), and incorporation of mcm5U and cm5U into a tRNAGly(U*CC) anticodon stem–loop oligomer sequence (RNA-I and RNA-II). Reaction conditions: a) Ac2O, Py, RT, overnight; b) BzCl, DMAP, NEt3, 0.5 h; c) CH2(COMe)2, DBU, THF, RT, overnight; d) NaOMe, MeOH, 50°C, 1 h; e) DMTr, Py, RT, overnight; f) TBDMSCl, Im, Py, RT, 10 h; g) (iPr2N)P(Cl)OCH2CH2CN, iPr2NEt, THF, RT, 4 h; h) standard solid-phase RNA synthesis and subsequent deprotection under ultramild conditions (see the Supporting Information). Bz=benzoyl, DBU=1,8-diazabicyclo[5.4.0]undec-7-ene, DMAP=4-dimethylaminopyridine, Im=imidazole, Py=pyridine, TBDMS=tert-butyldimethylsilyl, THF=tetrahydrofuran.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aravind L, Koonin EV. Genome Biol. 2001;2:RESEARCH0007. - PMC - PubMed
    2. Kurowski MA, Bhagwat AS, Papaj G, Bujnicki JM. BMC Genomics. 2003;4:48. - PMC - PubMed
    3. Loenarz C, Schofield CJ. Nat Chem Biol. 2008;4:152. - PubMed
    1. Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B. Proc Natl Acad Sci USA. 2002;99:16660. - PMC - PubMed
    2. Falnes PO, Johansen RF, Seeberg E. Nature. 2002;419:178. - PubMed
    3. Trewick SC, Henshaw TF, Hausinger RP, Lindahl T, Sedgwick B. Nature. 2002;419:174. - PubMed
    1. Bratlie MS, Drablos F. BMC Genomics. 2005;6:1. - PMC - PubMed
    1. Gerken T, et al. Science. 2007;318:1469. - PMC - PubMed
    1. Mishina Y, Duguid EM, He C. Chem Rev. 2006;106:215. and reference therein. - PMC - PubMed

Publication types